Key Finding
Moxibustion was the most effective acupoint stimulation therapy for irritable bowel syndrome, significantly reducing symptom severity and improving quality of life compared to conventional medication and other modalities including acupuncture.
Irritable bowel syndrome (IBS) is a common digestive condition that causes uncomfortable symptoms like abdominal pain, bloating, and changes in bowel habits, often significantly affecting daily life. Researchers wanted to find out which types of acupoint stimulation work best for IBS symptoms. They reviewed 12 high-quality studies involving 1,839 patients who received different treatments including acupuncture, moxibustion (a therapy using heated herbs near acupuncture points), or standard medication. The research team used sophisticated statistical methods to compare how well each treatment worked for reducing IBS symptoms and improving quality of life. The results showed that all acupoint stimulation therapies helped reduce symptom severity and improved patients' quality of life compared to conventional medication alone. Moxibustion emerged as the most effective treatment, showing substantial improvements in both symptom severity and quality of life. Acupuncture was the second most effective option. All treatments were found to be safe with acceptable side effect profiles. This is encouraging news for IBS patients seeking alternative or complementary treatments, as the chronic nature of this condition often requires long-term management strategies. These findings suggest that acupoint stimulation therapies, particularly moxibustion and acupuncture, may offer meaningful symptom relief for people struggling with IBS when conventional treatments aren't fully effective. If you're considering acupuncture or moxibustion for IBS, consult with a licensed acupuncturist who has experience treating digestive disorders.
This Bayesian network meta-analysis evaluated the comparative effectiveness of acupoint stimulation modalities for IBS treatment. Researchers systematically reviewed 12 RCTs encompassing 1,839 participants across five databases through November 2024. The study compared three interventions: acupuncture, moxibustion, and placebo against conventional medication. Primary outcomes measured symptom severity and quality of life using standardized instruments. Results demonstrated that moxibustion showed superior efficacy, significantly reducing symptom severity (MD = 101.50; 95% CrI: 80.36, 122.30) and improving quality of life (MD = -19.75; 95% CrI: -28.86, -10.75) compared to conventional medication. Acupuncture ranked second in effectiveness for both outcomes. All interventions demonstrated acceptable safety profiles with minimal adverse events. Clinical significance: This NMA provides robust evidence supporting moxibustion as the preferred acupoint stimulation modality for IBS management, followed by traditional acupuncture. These findings support integration of these modalities into comprehensive IBS treatment protocols, particularly for patients seeking non-pharmacological interventions or experiencing suboptimal responses to conventional therapies.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Different moxibustion temperatures activate distinct thermosensitive proteins and pathways that influence the phenotypic remodeling of primary lesion cells in rheumatoid arthritis, including fibroblast-like synoviocytes, macrophages, and T cells.
📌 Moxibustion significantly reduced arthritis severity in animal models with large effect sizes (SMD -3.72 for arthritis index) while suppressing pro-inflammatory cytokines and key signaling pathways including NF-κB and NLRP3 inflammasome.
📌 Three transdermal moxibustion compounds—Citral, α-Terpineol, and Borneol—were identified as targeting TNF-α to reduce rheumatoid arthritis through MAPK pathway inhibition and MMP modulation.